Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement

被引:180
|
作者
Kallinich, Tilmann
Haffner, Dieter
Niehues, Tim
Huss, Kristina
Lainka, Elke
Neudorf, Ulrich
Schaefer, Christof
Stojanov, Silvia
Timmann, Christian
Keitzer, Rolf
Ozdogan, Huri
Ozen, Seza
机构
[1] Univ Med Berlin, Dept Pediat Pneumol & Immunol, Berlin, Germany
[2] Univ Hosp Rostock, Dept Pediat, Rostock, Germany
[3] Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, D-4000 Dusseldorf, Germany
[4] Univ Duisburg Gesamthsch, Dept Pediat, D-4100 Duisburg, Germany
[5] Childrens Univ Hosp, Dept Infect Dis & Immunol, Munich, Germany
[6] Berliner Betrieb Zent Gesundheitl Aufugaben, Berlin, Germany
[7] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany
[8] Istanbul Univ, Cerrahpasa Med Sch, Cerrahpasa, Turkey
[9] Hacettepe Univ, Fac Med, Dept Pediat Nephrol & Rheumatol, Ankara, Turkey
关键词
familial Mediterranean fever; colchicine; evidence-based guidelines; treatment;
D O I
10.1542/peds.2006-1434
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The daily application of colchicine is the standard therapy for prophylaxis of attacks and amyloid deposition in familial Mediterranean fever. However, because of many issues (eg, dosage, time of introduction, etc), no standardized treatment recommendations have been established. In this work we review the available literature on colchicine use with respect to its indication, efficacy, mode of application, and safety in children and adolescents with familial Mediterranean fever. On the basis of this analysis, a consensus statement on the application of colchicine in children and adolescents with familial Mediterranean fever was developed by caregivers from Germany, Austria, and Turkey.
引用
收藏
页码:E474 / E483
页数:10
相关论文
共 50 条
  • [1] Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
    Fehime Kara Eroglu
    Nesrin Beşbaş
    Rezan Topaloglu
    Seza Ozen
    Rheumatology International, 2015, 35 : 1733 - 1737
  • [2] Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
    Eroglu, Fehime Kara
    Besbas, Nesrin
    Topaloglu, Rezan
    Ozen, Seza
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (10) : 1733 - 1737
  • [3] Familial Mediterranean Fever, Colchicine, and Pregnancy: A Case Report and Review of Literature
    Eroglu, Derya
    Beyhan, Hilal Karahan
    Yanik, Filiz
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 3 (01) : 65 - 69
  • [4] Colchicine treatment in children with familial Mediterranean fever
    Özkaya, N
    Yalçinkaya, F
    CLINICAL RHEUMATOLOGY, 2003, 22 (4-5) : 314 - 317
  • [5] Colchicine treatment in children with familial Mediterranean fever
    N. Özkaya
    F. Yalçınkaya
    Clinical Rheumatology, 2003, 22 : 314 - 317
  • [6] Once-daily use of colchicine in children with familial Mediterranean fever
    Kosan, C
    Özkan, B
    CLINICAL PEDIATRICS, 2004, 43 (07) : 605 - 608
  • [7] Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review
    Talerico, Rosa
    Cardillo, Carmine
    De Vito, Francesco
    Schinzari, Francesca
    Soldato, Manuel
    Giustiniani, Maria Cristina
    Verrecchia, Elena
    Manna, Raffaele
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [8] DISCONTINUATION OF COLCHICINE THERAPY IN CHILDREN WITH FAMILIAL MEDITERRANEAN FEVER
    Butbul, Yonatan
    Sliman, Rawan
    Fahoum, Shafe
    Berkun, Yackov
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 555 - 556
  • [9] Discontinuation of Colchicine Therapy in Children With Familial Mediterranean Fever
    Aviel, Yonatan Butbul
    Rawan, Silman
    Fahoum, Shafe
    Wexler, Isaiah
    Berkun, Yackov
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (11) : 1732 - 1735
  • [10] Colchicine is a Safe Drug in Children with Familial Mediterranean Fever
    Padeh, Shai
    Gerstein, Maya
    Berkun, Yackov
    JOURNAL OF PEDIATRICS, 2012, 161 (06): : 1142 - 1146